• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, May 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

KAIST team identifies the novel molecular signal for triggering septic…

Bioengineer.org by Bioengineer.org
January 28, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: KAIST

Professor Seyun Kim's team from KAIST reported the mechanism by which cellular signaling transduction network is exquisitely controlled in mediating innate immune response such as sepsis by the enzyme IPMK (Inositol polyphosphate multikinase) essential for inositol biosynthesis metabolism.

In collaboration with Professor Rho Hyun Seong at Seoul National University, the study's first author, Eunha Kim, a Ph.D. candidate in Department of Biological Sciences, performed a series of cellular, biochemical, and physiological experiments searching for the new function of IPMK enzyme in macrophages. The research findings were published in Science Advances on April 21.

Professor Kim's team has been investigating various inositol metabolites and their biosynthesis metabolism for several years and has multilaterally identified signaling actions of IPMK (Inositol polyphosphate multikinase) in the control of cellular growth and energy homeostasis.

This research showed that specific deletion of IPMK enzyme in macrophages could significantly reduce levels of inflammation and increase survival rates in mice when they were challenged by microbial septic shock as well as endotoxins. This suggests a role for IPMK enzyme in mediating innate inflammatory responses that are directly related to host defense against pathogenic bacterial infection.

The team further discovered that IPMK enzyme directly binds to TRAF6 protein, a key player in immune signaling, thus protecting TRAF6 protein from ubiquitination reactions that are involved in protein degradation. In addition, Kim and colleagues successfully verified this IPMK-dependent immune control by employing short peptides which can specifically interfere with the binding between IPMK enzyme and TRAF6 protein in macrophage cells.

This research revealed a novel function of IPMK enzyme in the fine tuning of innate immune signaling networks, suggesting a new direction for developing therapeutics targeting serious medical conditions such as neuroinflammation, type 2 diabetes, as well as polymicrobial sepsis that are developed from uncontrolled host immune responses. This research was funded by the Ministry of Science, ICT and Future Planning.

###

Media Contact

Younghye Cho
[email protected]
82-423-502-294
@KAISTPR

http://www.kaist.edu/english/

Original Source

http://www.kaist.ac.kr/_prog/_board/?code=ed_news&mode=V&no=63821&upr_ntt_no=63821&site_dvs_cd=en&menu_dvs_cd=060101 http://dx.doi.org/10.1126/sciadv.1602296

Share13Tweet8Share2ShareShareShare2

Related Posts

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact — Medicine

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact

May 13, 2026

Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)

May 13, 2026

Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds

May 12, 2026

Immune Protein Identified as Potential Target to Slow Parkinson’s Disease Progression

May 12, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    728 shares
    Share 290 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact

Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)

Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.